GSK Aktie
| 22,90EUR | 0,24EUR | 1,06% |
WKN DE: A3DMB5 / ISIN: GB00BN7SWP63
Diese Analysten bewerten die GSK-Aktie
| Analyst | Buy | Hold | Sell | Kursziel | Abstand | Datum |
|---|---|---|---|---|---|---|
| JP Morgan Chase & Co. | 17,00£ | -13,29% | 04.08.26 | |||
| Bernstein Research | 30,10£ | 53,53% | 03.08.26 | |||
| Deutsche Bank AG | 20,00£ | 2,01% | 30.07.26 | |||
| Jefferies & Company Inc. | 25,00£ | 27,52% | 28.07.26 | |||
| UBS AG | 19,40£ | -1,05% | 13.07.26 | |||
| Goldman Sachs Group Inc. | 18,90£ | -3,60% | 30.06.26 | |||
| Barclays Capital | 19,00£ | -3,09% | 30.06.26 | |||
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 20,00£ | 2,01% | 17.02.26 |
Historische Rating-Entwicklung
|
0
Buy
0
Hold
0
Sell
Aktuell
|
0
Buy
0
Hold
0
Sell
vor 1/2 Jahr
|
0
Buy
0
Hold
0
Sell
vor 1 Jahr
|